MA27172A1 - 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments - Google Patents

3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments

Info

Publication number
MA27172A1
MA27172A1 MA27803A MA27803A MA27172A1 MA 27172 A1 MA27172 A1 MA 27172A1 MA 27803 A MA27803 A MA 27803A MA 27803 A MA27803 A MA 27803A MA 27172 A1 MA27172 A1 MA 27172A1
Authority
MA
Morocco
Prior art keywords
oxdiazol
alcoxy
medicines
phenyl
production
Prior art date
Application number
MA27803A
Other languages
English (en)
French (fr)
Inventor
Karl Schoenafinger
Stefan Petry
Gunter Muller
Armin Bauer
Hubert Ott Heuer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of MA27172A1 publication Critical patent/MA27172A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
MA27803A 2002-02-28 2004-07-27 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments MA27172A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10208987A DE10208987A1 (de) 2002-02-28 2002-02-28 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen

Publications (1)

Publication Number Publication Date
MA27172A1 true MA27172A1 (fr) 2005-01-03

Family

ID=27740558

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27803A MA27172A1 (fr) 2002-02-28 2004-07-27 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments

Country Status (22)

Country Link
EP (1) EP1480960B1 (https=)
JP (1) JP4486363B2 (https=)
KR (1) KR20040095240A (https=)
CN (1) CN1639137A (https=)
AR (1) AR038701A1 (https=)
AT (1) ATE557012T1 (https=)
AU (1) AU2003226977A1 (https=)
BR (1) BR0307921A (https=)
CA (1) CA2477031A1 (https=)
CO (1) CO5611146A2 (https=)
DE (1) DE10208987A1 (https=)
HR (1) HRP20040782A2 (https=)
HU (1) HUP0402671A3 (https=)
IL (1) IL163683A0 (https=)
MA (1) MA27172A1 (https=)
MX (1) MXPA04007960A (https=)
NO (1) NO20044090L (https=)
PE (1) PE20030928A1 (https=)
PL (1) PL370423A1 (https=)
RU (1) RU2004128933A (https=)
TW (1) TW200400951A (https=)
WO (1) WO2003072555A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
JP2008517976A (ja) 2004-10-25 2008-05-29 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb1カンナビノイド受容体拮抗薬及びカリウムチャンネルオープナーから成る、真性糖尿病1型、肥満及び関連症状の治療用の医薬組成物
JP2011507952A (ja) * 2007-12-27 2011-03-10 バイアル−ポルテラ アンド シーエー,エス.エー. 医療用途用5−o−置換3−n−フェニル−1、3、4−オキサジアゾロン類
TW201028406A (en) 2008-12-23 2010-08-01 Bial Portela & Ca Sa 5-O-substituted 3-N-aryl-1,3,4-oxadiazolones for medical use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
TR200401217T4 (tr) * 2000-03-07 2004-06-21 Aventis Pharma Deutschland Gmbh İkameli 3-Fenil-5-Alkoksi-1,3,4-Oksdiazol-2-one (ve) hormona duyarlı lipazın önlenmesinde kullanılması

Also Published As

Publication number Publication date
TW200400951A (en) 2004-01-16
AU2003226977A1 (en) 2003-09-09
BR0307921A (pt) 2004-12-21
CA2477031A1 (en) 2003-09-04
IL163683A0 (en) 2005-12-18
ATE557012T1 (de) 2012-05-15
HUP0402671A3 (en) 2006-07-28
JP2005519085A (ja) 2005-06-30
MXPA04007960A (es) 2004-11-26
EP1480960A1 (de) 2004-12-01
AR038701A1 (es) 2005-01-26
WO2003072555A1 (de) 2003-09-04
JP4486363B2 (ja) 2010-06-23
PL370423A1 (en) 2005-05-30
NO20044090L (no) 2004-11-04
CN1639137A (zh) 2005-07-13
EP1480960B1 (de) 2012-05-09
PE20030928A1 (es) 2003-12-17
DE10208987A1 (de) 2003-09-11
CO5611146A2 (es) 2006-02-28
RU2004128933A (ru) 2005-04-20
HRP20040782A2 (en) 2005-02-28
HUP0402671A2 (hu) 2005-04-28
KR20040095240A (ko) 2004-11-12

Similar Documents

Publication Publication Date Title
PT1095025E (pt) Benzimidazoles sua producao e sua utilizacao como medicamentos
PT1362027E (pt) 6,7,8,9-tetra-hidro-5h-benzociclo-heptenilaminas aciladas e a sua utilização como fármacos
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
CY2015009PI2 (el) Ινδολινονες υποκατεστημενες στη θεση 6, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
AU2003292239A8 (en) Novel carboxamides, the production and use thereof as medicaments
PL1667993T3 (pl) Heteroarylo-podstawione pochodne 1,3-dihydroindol-2-onu i zawierające je leki
ATE432919T1 (de) Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE60042560D1 (de) System zum verabreichen von medikamenten in die nasenpassage
AU2003293757A1 (en) Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
IS7564A (is) Lyfjablanda með breytta losun
EP1624935A4 (en) ANTI-ADHESION COMPOUNDS AND USE METHOD THEREFOR
EE200300193A (et) Asendatud bensimidasoolid, nende kasutamine ja ravim
IL149400A0 (en) Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
PL374420A1 (pl) Proces wytwarzania kompozytu z kopolimeru blokowego i leku
ZA200604432B (en) Thiozolidinones production and use thereof as medicaments
FI20001656L (fi) Potilaan sõhk÷isten ominaisuksien seuraaminen
PL374879A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
EP1750693A4 (en) OKULOSELECTIVE MEDICINAL PRODUCTS AND PRODRUGS
MA27172A1 (fr) 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments
FR2870539B1 (fr) Nouvelles methodes et medicaments
ATE487741T1 (de) Mischungen aus von heparin abgeleiteten oligosacchariden, herstellung davon und pharmazeutische zusammensetzungen, die die mischungen enthalten
IL155853A0 (en) Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
AU2003254556A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
EP1745000A4 (en) NEW ANTHRACHINONE, MANUFACTURING METHOD AND USE THEREOF